Uveitis of the Eye

Links shared publicly online about this topic

About 10% of blindness is due to uveitis, or inflamed eye tissue. Smoking is now being linked with this disease http://tinyurl.com/ykwqc7r

sciencedaily.com — “About 10% of blindness is due to uveitis, or inflamed eye tissue. Smoking is now being linked with this disease http://tinyurl.com/ykwqc7rView full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 3, 2010 at 6:34 pm By:

DrJaySchwartz Dr. Jay Schwartz Doctor, Ophthalmologist, and Physician

About 10% of blindness is due to uveitis, or inflamed eye tissue. Smoking is now being linked with this disease http://tinyurl.com/ykwqc7r

2 years ago...

What Is Uveitis? What Causes Uveitis? What Is Iritis?

medicalnewstoday.com — “Uveitis is the inflammation of the uvea (or uceal tract), which is the middle layer of the eye. The uvea extends toward the front of the eye and consists of the iris (colored part of the eyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 6, 2009 at 4:34 pm By:

Lymphomation Lymphomation.org Support

Blurred or cloudy vision, headache, red, light-sensitive eyes? Get checked for Uveitis, #Lymphoma pt. http://bit.ly/14q9zZ

3 years ago...

Another serious eye disease, uveitis, linked to smoking

feeds.sciencedaily.com — “Smoking is already a known risk factor for age-related macular degeneration, cataract and thyroid eye disease. Now, the first study to specifically examine the impact of smoking on uveitis-inflammation of the eye's middle layer of tissue-indicates that tobacco smoke likely plays a role in this serious eye disease, as well. In the United States about 10 percent of blindness is caused by uveitis.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 1, 2010 at 7:14 pm By:

sciencedaily sciencedaily Health News

Another serious eye disease, uveitis, linked to smoking: Smoking is already a known risk factor for age-related ma... http://bit.ly/dy1XjY

2 years ago...

Infectious Disease Article | Uveitis

mdlinx.com — “Presumed tuberculous uveitis: diagnosis, management, and outcomeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 15, 2011 at 11:17 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Presumed tuberculous uveitis: diagnosis, management, and outcome: Eye http://bit.ly/gYJPbI #ID

1 year ago...

Can Retisert Be Used to Treat Uveitis?

eyedocnews.com — “Jancevski, MD and colleagues report on the safety of Retisert for patients with intermediate or posterior uveitis. Their study involved 64 eyes of 51View full resource at eyedocnews.com

  • View Related
  • Share

Most Recently Shared on May 12, 2010 at 5:45 pm By:

eyedocnews Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician

Discuss: Retisert Indicated for Uveitis?: By Dr. Randall WongJancevski, MD and colleagues report on the safety of ... http://bit.ly/9Sg8VD

2 years ago...

Uveitis means inflammation of the part of the eye called the uvea. Learn the causes, symptoms, and treatment options.

intelihealth.com — “Uveitis means inflammation of the part of the eye called the uvea. Learn the causes, symptoms, and treatment options.View full resource at intelihealth.com

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 6:27 pm By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

Uveitis means inflammation of the part of the eye called the uvea. Learn the causes, symptoms, and treatment options. http://bit.ly/bHyRue

2 years ago...

YouTube - Uveitis - Long term concerns

youtube.com — “Patrick DeRespinis MD Pediatric Ophthalmology | Residency: New Jersey Medical School | Fellowship:Manahattan Eye, Ear & Throat Hospital Author of "View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on January 24, 2011 at 3:20 am By:

Study shows two treatments for uveitis equally effective - News

virtualmedicalcentre.com — “Results of inflammatory eye disease research provide better treatment informationView full resource at virtualmedicalcentre.com

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 9:56 am By:

VirtualMedical VirtualMedicalCentre Health Site

Study shows two treatments for uveitis equally effective http://t.co/67q42WI #Healthnews

9 months ago...

Orphan Drug Status for Sirolimus for Non-Infectious Uveitis - MPR

empr.com — “Santen Inc. announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis, and non-infectious uveitis affecting the posterior segment of the eye.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 2:32 pm By:

eMPR MPR Medical Publisher

Orphan Drug Status for Sirolimus for Non-Infectious #Uveitis http://t.co/vLl947Hz

7 months ago...

Leading Treatments for Uveitis Found to be Similarly Effective, Increasing Patient Options

newswise.com — “A team of researchers comparing the two leading treatment approaches for the eye condition uveitis, which is the fifth leading cause of blindness in the US, have found that a time-release corticosteroid implant placed surgically in the eye is similarly effective in treating the disease as anti-inflammatory corticosteroids and immunosuppressive drugs taken orally. The report was published online this week in the journal Ophthalmology.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on August 18, 2011 at 6:45 pm By:

newswise newswise Health Communicator and Health News

Leading Treatments for Uveitis Found to be Similarly Effective, Increasing Patient Options: A team of researcher... http://t.co/HaQq0ej

9 months ago...

Time-release corticosteroid implant effective in treating uveitis

news-medical.net — “A team of researchers comparing the two leading treatment approaches for the eye condition uveitis, which is the fifth leading cause of blindness in the US, have found that a time-release corticosteroid implant placed surgically in the eye is similarly effective in treating the disease as anti-inflammatory corticosteroids and immunosuppressive drugs taken orally. The report was published online this week in the journal Ophthalmology.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 19, 2011 at 9:59 am By:

NewsMedical News-Medical.Net Health News

Time-release corticosteroid implant effective in treating uveitis: A team of researchers comparing the two leadi... http://t.co/x6mH2Uw

9 months ago...

Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

agn.client.shareholder.com — “Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the EyeView full resource at agn.client.shareholder.com

  • View Related
  • Share

Most Recently Shared on September 24, 2010 at 8:37 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Allergan Gets FDA OK 4 OZURDEX(R) - Trtmnt Option 4 Non-Infectious Uveitis Affecting Posterior Segment of the Eye http://ow.ly/2JA4J

2 years ago...

EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Uveitis

medicalnewstoday.com — “EyeGate Pharma, the leader in non-invasive ocular drug delivery, announces the completion of a Phase II study of its lead product candidate, EGP-437, for the treatment of anterior uveitis. In theView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 3:58 pm By:

mnt_clinical MNT Clinical Trials Health News

EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Uveitis: EyeGate Pharma, the leader.. http://bit.ly/VdmqB

3 years ago...

EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Uveitis

medicalnewstoday.com — “EyeGate Pharma, a privately held venture-backed pharmaceutical company developing a non-invasive ocular drug delivery platform and ocular therapeutics, announces today the completion of a Phase IIView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 25, 2010 at 8:37 pm By:

medical_tweets medical_tweets Health News

EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Uveitis EyeGate Pharma, a privately held.. http://bit.ly/aS159B

2 years ago...

Ozurdex approved for non-infectious uveitis - ONA

oncologynurseadvisor.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on September 28, 2010 at 6:07 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Related Health Centers

Featuring the top 3 experts for this topic

  • DrJaySchwartz

    Dr. Jay Schwartz

    Schwartz Laser Eye Center is Arizona's most trusted ophthalmology center for LASIK & more. Official team eye doctor for the Suns, Dbacks, Coyotes & Mercury.

    View Profile

  • Lymphomation

    Lymphomation.org

    Lymphomation.org/Patients Against Lymphoma -- Providing support and timely access to evidence-based information on lymphomas and their treatment.

    View Profile

  • sciencedaily

    sciencedaily

    Visit ScienceDaily to read breaking news about the latest discoveries in science, health, the environment, and technology.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390